Moderna begins 3rd stage of trial for COVID-19 vaccine candidate mRNA-1273

Monday, July 27, 2020 - 08:00 in Health & Medicine

Drugmaker Moderna said Monday it has begun a 30,000-patient, third-stage clinical trial for its COVID-19 vaccine candidate -- a day after receiving an additional $472 million from the U.S. government.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net